Literature DB >> 25213404

Comparing a marginal structural model with a Cox proportional hazard model to estimate the effect of time-dependent drug use in observational studies: statin use for primary prevention of cardiovascular disease as an example from the Rotterdam Study.

Catherine E de Keyser1, Maarten J G Leening, Silvana A Romio, J Wouter Jukema, Albert Hofman, M Arfan Ikram, Oscar H Franco, Theo Stijnen, Bruno H Stricker.   

Abstract

When studying the causal effect of drug use in observational data, marginal structural modeling (MSM) can be used to adjust for time-dependent confounders that are affected by previous treatment. The objective of this study was to compare traditional Cox proportional hazard models (with and without time-dependent covariates) with MSM to study causal effects of time-dependent drug use. The example of primary prevention of cardiovascular disease (CVD) with statins was examined using up to 17.7 years of follow-up from 4,654 participants of the observational prospective population-based Rotterdam Study. In the MSM model, the weight was based on measurements of established cardiovascular risk factors and co-morbidity. In general, we could not demonstrate important differences in results from the Cox models and MSM. Results from analysis on duration of statin use suggested that substantial residual confounding by indication was not accounted for during the period shortly after statin initiation. In conclusion, although on theoretical grounds MSM is an elegant technique, lack of data on the precise time-dependent confounders, such as indication of treatment or other considerations of the prescribing physician jeopardizes the calculation of valid weights. Confounding remains a hurdle in observational effectiveness research on preventive drugs with a multitude of prescription determinants.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25213404     DOI: 10.1007/s10654-014-9951-y

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  32 in total

1.  Assessment and control for confounding by indication in observational studies.

Authors:  B M Psaty; T D Koepsell; D Lin; N S Weiss; D S Siscovick; F R Rosendaal; M Pahor; C D Furberg
Journal:  J Am Geriatr Soc       Date:  1999-06       Impact factor: 5.562

2.  Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study.

Authors:  R B D'Agostino; M L Lee; A J Belanger; L A Cupples; K Anderson; W B Kannel
Journal:  Stat Med       Date:  1990-12       Impact factor: 2.373

Review 3.  Application of marginal structural models in pharmacoepidemiologic studies: a systematic review.

Authors:  Shibing Yang; Charles B Eaton; Juan Lu; Kate L Lapane
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-01-24       Impact factor: 2.890

4.  Socioeconomic differences in stroke among Dutch elderly women: the Rotterdam Study.

Authors:  C T van Rossum; H van de Mheen; M M Breteler; D E Grobbee; J P Mackenbach
Journal:  Stroke       Date:  1999-02       Impact factor: 7.914

5.  Confounding by indication: an example of variation in the use of epidemiologic terminology.

Authors:  M Salas; A Hofman; B H Stricker
Journal:  Am J Epidemiol       Date:  1999-06-01       Impact factor: 4.897

Review 6.  An overview of the objectives of and the approaches to propensity score analyses.

Authors:  Georg Heinze; Peter Jüni
Journal:  Eur Heart J       Date:  2011-02-28       Impact factor: 29.983

7.  Representation of elderly persons and women in published randomized trials of acute coronary syndromes.

Authors:  P Y Lee; K P Alexander; B G Hammill; S K Pasquali; E D Peterson
Journal:  JAMA       Date:  2001-08-08       Impact factor: 56.272

8.  Aspirin in the primary prevention of cardiovascular disease in the Women's Health Study: effect of noncompliance.

Authors:  Nancy R Cook; Stephen R Cole; Julie E Buring
Journal:  Eur J Epidemiol       Date:  2012-06-15       Impact factor: 8.082

9.  Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute.

Authors:  Mark A Hlatky; Pamela S Douglas; Nakela L Cook; Barbara Wells; Emelia J Benjamin; Kay Dickersin; David C Goff; Alan T Hirsch; Elaine M Hylek; Eric D Peterson; Véronique L Roger; Joseph V Selby; James E Udelson; Michael S Lauer
Journal:  J Am Coll Cardiol       Date:  2012-07-11       Impact factor: 24.094

10.  Trends in stroke incidence rates and stroke risk factors in Rotterdam, the Netherlands from 1990 to 2008.

Authors:  Renske G Wieberdink; M Arfan Ikram; Albert Hofman; Peter J Koudstaal; Monique M B Breteler
Journal:  Eur J Epidemiol       Date:  2012-03-17       Impact factor: 8.082

View more
  7 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

2.  Caution: work in progress : While the methodological "revolution" deserves in-depth study, clinical researchers and senior epidemiologists should not be disenfranchised.

Authors:  Miquel Porta; Francisco Bolúmar
Journal:  Eur J Epidemiol       Date:  2016-07-14       Impact factor: 8.082

3.  Effectiveness of sodium bicarbonate infusion on mortality in septic patients with metabolic acidosis.

Authors:  Zhongheng Zhang; Carlie Zhu; Lei Mo; Yucai Hong
Journal:  Intensive Care Med       Date:  2018-09-25       Impact factor: 17.440

4.  The impact of adherence to inhaled drugs on 5-year survival in COPD patients: a time dependent approach.

Authors:  Valeria Belleudi; Mirko Di Martino; Silvia Cascini; Ursula Kirchmayer; Riccardo Pistelli; Giulio Formoso; Danilo Fusco; Marina Davoli; Nera Agabiti
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-07-11       Impact factor: 2.890

5.  Statin Treatment and Clinical Outcomes of Heart Failure Among Africans: An Inverse Probability Treatment Weighted Analysis.

Authors:  Kwadwo Osei Bonsu; Isaac Kofi Owusu; Kwame Ohene Buabeng; Daniel D Reidpath; Amudha Kadirvelu
Journal:  J Am Heart Assoc       Date:  2017-04-01       Impact factor: 5.501

6.  Adherence to a priori-Defined Diet Quality Indices Throughout the Early Disease Course Is Associated With Survival in Head and Neck Cancer Survivors: An Application Involving Marginal Structural Models.

Authors:  Christian A Maino Vieytes; Sandra L Rodriguez-Zas; Zeynep Madak-Erdogan; Rebecca L Smith; Katie R Zarins; Gregory T Wolf; Laura S Rozek; Alison M Mondul; Anna E Arthur
Journal:  Front Nutr       Date:  2022-04-25

7.  Effectiveness of sodium bicarbonate infusion on mortality for elderly septic patients with acute metabolic acidosis.

Authors:  Sai Huang; Yaojun Peng; Lili Wang; Jing Wang; Xuan Zhou; Xiang Cui; Li Chen; Bo Yang; Cong Feng
Journal:  Front Pharmacol       Date:  2022-09-13       Impact factor: 5.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.